The acquisition will involve an upfront payment of $925 million by Novartis, with the potential for additional payments totaling up to $2.15 billion, as per the company's statement.

Natsume has offered a first look at Harvest Moon: The Winds of Anthos, which will be the newest entry in the Harvest Moon series.

The Harvest Moon: The Winds of Anthos logo, which features a green landscape with looming snow-covered mountains. The release also includes some story particulars.

An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention.

Novartis NOVN -0.37% agreed to acquire Blackstone Life Sciences’ Anthos Therapeutics for up to $3.08 billion to boost its cardiovascular-drug pipeline. The deal means the Swiss pharmaceutical ...

Swiss pharmaceutical giant Novartis announced on Tuesday the purchase of Cambridge-based biopharma firm Anthos Therapeutics for $925 million upfront. The deal, which is expected to close in the ...

Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abelacimab, a novel factor XI ...

Biotechnology company Anthos Therapeutics has received Fast Track designation from the U.S. Food and Drug Administration for abelacimab, a monoclonal antibody, for the prevention of stroke and ...

But for today, we’re getting a chance to see Harvest Moon: The Winds of Anthos gameplay for the first time. Previously, the company only showed screenshots for the game and its logo.

Check out the first images from Harvest Moon: The Winds Of Anthos, as Natsume will release the game later in 2023.

Natsume has released the first information and screenshots for Harvest Moon: The Winds of Anthos, the latest entry in Harvest Moon and due out later in 2023. Platforms have yet to be announced.